NeueHealth (NYSE:NEUE) Director Paul Edward Walker Sells 3,915 Shares

Key Points

• Director Paul Edward Walker sold 3,915 shares of NeueHealth stock at an average price of $6.75, reducing his ownership by 0.79% to 488,702 shares valued at approximately $3.3 million.
• NeueHealth's recent quarterly earnings report showed an EPS of ($1.68), beating estimates, but revenue of $209.08 million fell short of expectations of $249.50 million.
• Institutional investors hold approximately 63.88% of NeueHealth stock, with PenderFund Capital Management recently acquiring a new position valued at around $197,000.

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) Director Paul Edward Walker sold 3,915 shares of NeueHealth stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $6.75, for a total value of $26,426.25. Following the sale, the director owned 488,702 shares in the company, valued at $3,298,738.50. The trade was a 0.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

NeueHealth Price Performance

NEUE remained flat at $6.75 on Monday. The stock has a 50 day moving average of $6.72 and a two-hundred day moving average of $6.72. NeueHealth, Inc. has a 52 week low of $3.79 and a 52 week high of $7.66. The stock has a market cap of $60.94 million, a price-to-earnings ratio of -0.42 and a beta of 0.59.

NeueHealth (NYSE:NEUE - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($1.68) EPS for the quarter, topping the consensus estimate of ($4.77) by $3.09. The business had revenue of $209.08 million for the quarter, compared to analysts' expectations of $249.50 million. On average, sell-side analysts expect that NeueHealth, Inc. will post -9.13 EPS for the current year.

Institutional Investors Weigh In On NeueHealth

An institutional investor recently bought a new position in NeueHealth stock. PenderFund Capital Management Ltd. purchased a new position in NeueHealth, Inc. (NYSE:NEUE - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 29,115 shares of the company's stock, valued at approximately $197,000. PenderFund Capital Management Ltd. owned approximately 0.33% of NeueHealth at the end of the most recent quarter. 63.88% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a "sell (e+)" rating on shares of NeueHealth in a report on Saturday, September 27th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, NeueHealth has an average rating of "Reduce" and an average target price of $7.00.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.